0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Screening Technology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-22I5727
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Screening Technology Market Insights Forecast to 2028
BUY CHAPTERS

Global Cancer Screening Technology Market Research Report 2025

Code: QYRE-Auto-22I5727
Report
June 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cancer Screening Technology Market

The global market for Cancer Screening Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Screening Technology in Lung Cancer Screening is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Screening Technology include Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Technology.
The Cancer Screening Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Screening Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Screening Technology Market Report

Report Metric Details
Report Name Cancer Screening Technology Market
Segment by Type
  • Instrument-based Inspection
  • Platform-based Inspection
Segment by Application
  • Lung Cancer Screening
  • Breast Cancer Screening
  • Prostate Cancer Screening
  • Colorectal Cancer Screening
  • Blood Cancer Screening
  • Liver Cancer Screening
  • Pancreatic Cancer Screening
  • Skin Cancer Screening
  • Cervical Cancer Screening
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Screening Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Screening Technology Market report?

Ans: The main players in the Cancer Screening Technology Market are Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics

What are the Application segmentation covered in the Cancer Screening Technology Market report?

Ans: The Applications covered in the Cancer Screening Technology Market report are Lung Cancer Screening, Breast Cancer Screening, Prostate Cancer Screening, Colorectal Cancer Screening, Blood Cancer Screening, Liver Cancer Screening, Pancreatic Cancer Screening, Skin Cancer Screening, Cervical Cancer Screening, Other

What are the Type segmentation covered in the Cancer Screening Technology Market report?

Ans: The Types covered in the Cancer Screening Technology Market report are Instrument-based Inspection, Platform-based Inspection

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument-based Inspection
1.2.3 Platform-based Inspection
1.3 Market by Application
1.3.1 Global Cancer Screening Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer Screening
1.3.3 Breast Cancer Screening
1.3.4 Prostate Cancer Screening
1.3.5 Colorectal Cancer Screening
1.3.6 Blood Cancer Screening
1.3.7 Liver Cancer Screening
1.3.8 Pancreatic Cancer Screening
1.3.9 Skin Cancer Screening
1.3.10 Cervical Cancer Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Technology Market Perspective (2020-2031)
2.2 Global Cancer Screening Technology Growth Trends by Region
2.2.1 Global Cancer Screening Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Screening Technology Historic Market Size by Region (2020-2025)
2.2.3 Cancer Screening Technology Forecasted Market Size by Region (2026-2031)
2.3 Cancer Screening Technology Market Dynamics
2.3.1 Cancer Screening Technology Industry Trends
2.3.2 Cancer Screening Technology Market Drivers
2.3.3 Cancer Screening Technology Market Challenges
2.3.4 Cancer Screening Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Technology Players by Revenue
3.1.1 Global Top Cancer Screening Technology Players by Revenue (2020-2025)
3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Screening Technology Revenue
3.4 Global Cancer Screening Technology Market Concentration Ratio
3.4.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2024
3.5 Global Key Players of Cancer Screening Technology Head office and Area Served
3.6 Global Key Players of Cancer Screening Technology, Product and Application
3.7 Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Technology Breakdown Data by Type
4.1 Global Cancer Screening Technology Historic Market Size by Type (2020-2025)
4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031)
5 Cancer Screening Technology Breakdown Data by Application
5.1 Global Cancer Screening Technology Historic Market Size by Application (2020-2025)
5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Screening Technology Market Size (2020-2031)
6.2 North America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Screening Technology Market Size by Country (2020-2025)
6.4 North America Cancer Screening Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Technology Market Size (2020-2031)
7.2 Europe Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Screening Technology Market Size by Country (2020-2025)
7.4 Europe Cancer Screening Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Technology Market Size (2020-2031)
8.2 Asia-Pacific Cancer Screening Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Technology Market Size (2020-2031)
9.2 Latin America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Screening Technology Market Size by Country (2020-2025)
9.4 Latin America Cancer Screening Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Technology Market Size (2020-2031)
10.2 Middle East & Africa Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cancer Screening Technology Introduction
11.1.4 Abbott Revenue in Cancer Screening Technology Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Cancer Screening Technology Introduction
11.2.4 BD Revenue in Cancer Screening Technology Business (2020-2025)
11.2.5 BD Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Cancer Screening Technology Introduction
11.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cancer Screening Technology Introduction
11.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025)
11.4.5 GE Healthcare Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Olympus Corporation
11.6.1 Olympus Corporation Company Details
11.6.2 Olympus Corporation Business Overview
11.6.3 Olympus Corporation Cancer Screening Technology Introduction
11.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.6.5 Olympus Corporation Recent Development
11.7 FUJIFILM Corporation
11.7.1 FUJIFILM Corporation Company Details
11.7.2 FUJIFILM Corporation Business Overview
11.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
11.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.7.5 FUJIFILM Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Screening Technology Introduction
11.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Cancer Screening Technology Introduction
11.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025)
11.9.5 Eiken Chemical Recent Development
11.10 Hitachi Chemical (Kyowa Medex)
11.10.1 Hitachi Chemical (Kyowa Medex) Company Details
11.10.2 Hitachi Chemical (Kyowa Medex) Business Overview
11.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
11.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025)
11.10.5 Hitachi Chemical (Kyowa Medex) Recent Development
11.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
11.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
11.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
11.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025)
11.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Cancer Screening Technology Introduction
11.12.4 Sysmex Revenue in Cancer Screening Technology Business (2020-2025)
11.12.5 Sysmex Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Technology Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Technology Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025)
11.14.5 R-Biopharm Recent Development
11.15 Immunostics
11.15.1 Immunostics Company Details
11.15.2 Immunostics Business Overview
11.15.3 Immunostics Cancer Screening Technology Introduction
11.15.4 Immunostics Revenue in Cancer Screening Technology Business (2020-2025)
11.15.5 Immunostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cancer Screening Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Instrument-based Inspection
 Table 3. Key Players of Platform-based Inspection
 Table 4. Global Cancer Screening Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cancer Screening Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cancer Screening Technology Market Share by Region (2020-2025)
 Table 8. Global Cancer Screening Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cancer Screening Technology Market Share by Region (2026-2031)
 Table 10. Cancer Screening Technology Market Trends
 Table 11. Cancer Screening Technology Market Drivers
 Table 12. Cancer Screening Technology Market Challenges
 Table 13. Cancer Screening Technology Market Restraints
 Table 14. Global Cancer Screening Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cancer Screening Technology Market Share by Players (2020-2025)
 Table 16. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
 Table 17. Ranking of Global Top Cancer Screening Technology Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cancer Screening Technology Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cancer Screening Technology, Headquarters and Area Served
 Table 20. Global Key Players of Cancer Screening Technology, Product and Application
 Table 21. Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cancer Screening Technology Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cancer Screening Technology Revenue Market Share by Type (2020-2025)
 Table 25. Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cancer Screening Technology Revenue Market Share by Type (2026-2031)
 Table 27. Global Cancer Screening Technology Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cancer Screening Technology Revenue Market Share by Application (2020-2025)
 Table 29. Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cancer Screening Technology Revenue Market Share by Application (2026-2031)
 Table 31. North America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cancer Screening Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Cancer Screening Technology Product
 Table 49. Abbott Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. BD Company Details
 Table 52. BD Business Overview
 Table 53. BD Cancer Screening Technology Product
 Table 54. BD Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 55. BD Recent Development
 Table 56. Siemens Healthineers Company Details
 Table 57. Siemens Healthineers Business Overview
 Table 58. Siemens Healthineers Cancer Screening Technology Product
 Table 59. Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 60. Siemens Healthineers Recent Development
 Table 61. GE Healthcare Company Details
 Table 62. GE Healthcare Business Overview
 Table 63. GE Healthcare Cancer Screening Technology Product
 Table 64. GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 65. GE Healthcare Recent Development
 Table 66. F. Hoffmann-La Roche Company Details
 Table 67. F. Hoffmann-La Roche Business Overview
 Table 68. F. Hoffmann-La Roche Cancer Screening Technology Product
 Table 69. F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 70. F. Hoffmann-La Roche Recent Development
 Table 71. Olympus Corporation Company Details
 Table 72. Olympus Corporation Business Overview
 Table 73. Olympus Corporation Cancer Screening Technology Product
 Table 74. Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 75. Olympus Corporation Recent Development
 Table 76. FUJIFILM Corporation Company Details
 Table 77. FUJIFILM Corporation Business Overview
 Table 78. FUJIFILM Corporation Cancer Screening Technology Product
 Table 79. FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 80. FUJIFILM Corporation Recent Development
 Table 81. Agilent Technologies Company Details
 Table 82. Agilent Technologies Business Overview
 Table 83. Agilent Technologies Cancer Screening Technology Product
 Table 84. Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 85. Agilent Technologies Recent Development
 Table 86. Eiken Chemical Company Details
 Table 87. Eiken Chemical Business Overview
 Table 88. Eiken Chemical Cancer Screening Technology Product
 Table 89. Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 90. Eiken Chemical Recent Development
 Table 91. Hitachi Chemical (Kyowa Medex) Company Details
 Table 92. Hitachi Chemical (Kyowa Medex) Business Overview
 Table 93. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Product
 Table 94. Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 95. Hitachi Chemical (Kyowa Medex) Recent Development
 Table 96. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
 Table 97. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
 Table 98. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Product
 Table 99. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 100. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
 Table 101. Sysmex Company Details
 Table 102. Sysmex Business Overview
 Table 103. Sysmex Cancer Screening Technology Product
 Table 104. Sysmex Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 105. Sysmex Recent Development
 Table 106. QIAGEN Company Details
 Table 107. QIAGEN Business Overview
 Table 108. QIAGEN Cancer Screening Technology Product
 Table 109. QIAGEN Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 110. QIAGEN Recent Development
 Table 111. R-Biopharm Company Details
 Table 112. R-Biopharm Business Overview
 Table 113. R-Biopharm Cancer Screening Technology Product
 Table 114. R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 115. R-Biopharm Recent Development
 Table 116. Immunostics Company Details
 Table 117. Immunostics Business Overview
 Table 118. Immunostics Cancer Screening Technology Product
 Table 119. Immunostics Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
 Table 120. Immunostics Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Cancer Screening Technology Picture
 Figure 2. Global Cancer Screening Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Screening Technology Market Share by Type: 2024 VS 2031
 Figure 4. Instrument-based Inspection Features
 Figure 5. Platform-based Inspection Features
 Figure 6. Global Cancer Screening Technology Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cancer Screening Technology Market Share by Application: 2024 VS 2031
 Figure 8. Lung Cancer Screening Case Studies
 Figure 9. Breast Cancer Screening Case Studies
 Figure 10. Prostate Cancer Screening Case Studies
 Figure 11. Colorectal Cancer Screening Case Studies
 Figure 12. Blood Cancer Screening Case Studies
 Figure 13. Liver Cancer Screening Case Studies
 Figure 14. Pancreatic Cancer Screening Case Studies
 Figure 15. Skin Cancer Screening Case Studies
 Figure 16. Cervical Cancer Screening Case Studies
 Figure 17. Cancer Screening Technology Report Years Considered
 Figure 18. Global Cancer Screening Technology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Cancer Screening Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Cancer Screening Technology Market Share by Region: 2024 VS 2031
 Figure 21. Global Cancer Screening Technology Market Share by Players in 2024
 Figure 22. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Cancer Screening Technology Revenue in 2024
 Figure 24. North America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Cancer Screening Technology Market Share by Country (2020-2031)
 Figure 26. United States Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Cancer Screening Technology Market Share by Country (2020-2031)
 Figure 30. Germany Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cancer Screening Technology Market Share by Region (2020-2031)
 Figure 38. China Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Cancer Screening Technology Market Share by Country (2020-2031)
 Figure 46. Mexico Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Cancer Screening Technology Market Share by Country (2020-2031)
 Figure 50. Turkey Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Abbott Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 54. BD Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 55. Siemens Healthineers Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 56. GE Healthcare Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 58. Olympus Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 59. FUJIFILM Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 60. Agilent Technologies Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 61. Eiken Chemical Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 62. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 63. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 64. Sysmex Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 65. QIAGEN Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 66. R-Biopharm Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 67. Immunostics Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart